본문 바로가기

Downregulation of NKG2DLs by TGF-beta in human lung cancer cells

Downregulation of NKG2DLs by TGF-β in human lung cancer cells

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q3Scopus Q3
저널
BMC IMMUNOLOGY22(1) · 2021
피인용
Web of Science 24Scopus 26
FWCI (Scopus)
0.73
JCR IF
JCR 2020 3.615
ISSN
1471-2172

저자

  1. 이영신제1저자Department of Biochemistry, Pusan National University School of Medicine, Yangsan, 50162, South Korea
  2. 최호정Department of Biochemistry, Pusan National University School of Medicine, Yangsan, 50162, South Korea
  3. 조해령PNU BK21 Plus Biomedical Science Education Center, Pusan National University School of Medicine, Yangsan, 50612, South Korea
  4. Son, Woo-ChangDepartment of Research Center, Dongnam Institute of Radiological and Medical Sciences, Gijang, Busan, 46033, South Korea
  5. Park, You-SooDepartment of Research Center, Dongnam Institute of Radiological and Medical Sciences, Gijang, Busan, 46033, South Korea
  6. 강치덕Department of Biochemistry, Pusan National University School of Medicine, Yangsan, 50162, South Korea
  7. 배재호교신저자PNU BK21 Plus Biomedical Science Education Center, Pusan National University School of Medicine, Yangsan, 50612, South Korea

초록

BackgroundTransforming growth factor beta (TGF-beta) is a typical immuno-inhibitory cytokine and highly secreted by lung cancer cells. It was supposed that its immunosuppressive effects to NK cell might be related with the altered expression of activating and inhibitory molecules in lung cancer cells. In this study, we examined the expression of NKG2DLs, PD-L1 and PD-L2 in lung cancer cells after treatment of TGF-beta and a TGF-beta inhibitor, Galunisertib (LY2157299).ResultsTGF-beta reduced the level of surface proteins of five NKG2DLs without altered transcription levels in lung cancer cells. Galunisertib reversed the effect of TGF-beta on the expression of NKG2DLs. Since MMP inhibitors, MMPi III and MMP2 inhibitor I, restored the reduced expression of NKG2DLs after treatment of TGF-beta, it was thought that TGF-beta induced the expression of MMP2 which facilitated the shedding of the NKG2DLs in cancer cells. However, the expression of PD-L1, L2 were not changed by treatment with TGF-beta or Galunisertib.ConclusionsTherefore, inhibition of TGF-beta might reverse the immunosuppressive status on immune cells and restore NK cell mediated anticancer immune responses by upregulation of NKG2DLs in cancer cells.

키워드

NKG2D ligandsTransforming growth factor betaMatrix metalloproteinaseGROWTH-FACTOR-BETANATURAL-KILLER-CELLSURFACE EXPRESSIONIMMUNE-RESPONSENK CELLST-CELLSLIGANDSIMMUNOSUPPRESSIONIMMUNOTHERAPYGLIOBLASTOMA

식별자

Scopus EID
2-s2.0-85109915892
WoS UID
000674511700001